BuyMeWhiskeyStock analysisAnswersMDLN news
Home › Stock analysis › MDLN

Medline (MDLN) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET

Updated Oct 15, 2026, 4:00 PM ET

What changed since yesterday

MDLN rises 1.8% to $36.57, a 1-month high. Closed at $36.57, +1.78% vs the prior close of $35.93. Day range $35.88–$36.87, opened at $35.88.

Last close$36.57+1.78%
Day range35.88–36.87
Open35.88
Volume7.66M
52-week range31.49–50.88
Avg volume (20d)9.06M

MDLN daily analysis — what happened

A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.

Oct 15, 2026 — MDLN rises 1.8% to $36.57, a 1-month high
Oct 14, 2026 — MDLN rises 0.6% to $35.93
Oct 13, 2026 — MDLN ends flat (-0.2%) to $35.70
Oct 12, 2026 — MDLN dips 1.4% to $35.76
Oct 9, 2026 — MDLN rises 1.5% to $36.26, a 1-month high
Oct 8, 2026 — MDLN rises 0.8% to $35.74
Oct 7, 2026 — MDLN ends flat (-0.3%) to $35.45
Oct 6, 2026 — MDLN dips 0.7% to $35.55
Oct 5, 2026 — MDLN rises 0.5% to $35.80, 3 up days in a row
Oct 2, 2026 — MDLN rises 1.9% to $35.61

MDLN latest news & SEC filings

Every SEC filing by or about MDLN in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.

Oct 15, 2026 · 8-K — Current report

Current report — a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001104659-26-116255

Oct 13, 2026 · 4 — Insider trade report (Form 4)

Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001193125-26-419824

Oct 6, 2026 · 4 — Insider trade report (Form 4)

Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001193125-26-416053

Aug 21, 2026 · 4 — Insider trade report (Form 4)

Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001193125-26-361183

Aug 21, 2026 · 4 — Insider trade report (Form 4)

Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings

Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).

Source: SEC EDGAR filing 0001193125-26-361185

Aug 17, 2026 · 4 — Insider trade report (Form 4)

Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001193125-26-354079

Aug 11, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001193125-26-345223

Aug 11, 2026 · 4 — Insider trade report (Form 4)

Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings

Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.

Source: SEC EDGAR filing 0001193125-26-343561

Aug 7, 2026 · SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)

Update to a passive 5%+ stake (13G)

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0001193125-26-340351

Aug 6, 2026 · SCHEDULE 13G — Passive stake (13G)

Passive stake (13G) — an investor reported owning more than 5%

Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.

Source: SEC EDGAR filing 0000315066-26-002081

Aug 5, 2026 · 10-Q — Quarterly report (unaudited financial statements for the quarter)

Quarterly report (unaudited financial statements for the quarter)

Quarter ended Jun 27, 2026:

Source: SEC EDGAR filing 0002046386-26-000051

Aug 5, 2026 · 8-K — Current report

Current report — a filing companies must make within 4 business days of a major event

This is a results-day filing: the earnings press release is attached as an exhibit.

Source: SEC EDGAR filing 0002046386-26-000049

Jul 9, 2026 · 8-K — Current report

Current report — a filing companies must make within 4 business days of a major event

Source: SEC EDGAR filing 0001104659-26-082249

Things to know before you trade MDLN

MDLN market data (last 20 sessions)

DateOpenHighLowCloseVolume
Oct 15, 202635.8836.8735.8836.577.66M
Oct 14, 202635.5335.9835.3535.934.64M
Oct 13, 202635.6535.9634.9135.704.36M
Oct 12, 202636.2936.4435.6735.764.04M
Oct 9, 202635.6236.3835.4036.265.33M
Oct 8, 202635.1335.9735.0135.7410.19M
Oct 7, 202635.5535.9735.2135.454.47M
Oct 6, 202635.9836.8835.3035.558.88M
Oct 5, 202635.4436.2435.1835.8010.61M
Oct 2, 202635.3535.7234.8835.6113.27M
Oct 1, 202634.8535.2834.1434.9411.73M
Sep 30, 202634.9335.7534.4734.709.10M
Sep 29, 202635.0235.1934.5334.9811.92M
Sep 28, 202634.5035.3034.0435.0710.07M
Sep 25, 202634.8435.2934.4734.707.80M
Sep 24, 202634.2335.0433.8634.667.66M
Sep 23, 202634.1534.5933.8334.308.59M
Sep 22, 202632.5534.6232.3834.4310.45M
Sep 21, 202631.7232.4431.6331.9610.49M
Sep 18, 202632.1632.3331.4931.6419.95M

About Medline

Medline (MDLN) is listed on the Nasdaq and classified by the SEC under “Surgical & Medical Instruments & Apparatus”. Its business address is in NORTHFIELD, IL. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 2046386.

MDLN board of directors & executives

From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).

Directors

NameRoleLatest filing
Joseph BarattaDirectorDec 17, 2025
Jacob BestDirectorDec 17, 2025
Todd M BluedornDirectorJun 15, 2026
James M BoyleChief Executive OfficerAug 21, 2026
Richard A GalantiDirectorJun 15, 2026
Patrick J HealyDirectorJun 1, 2026
Andrew J. MillsDirectorDec 22, 2025
Charles N. MillsDirectorDec 22, 2025
Robert R. SchmidtDirectorJan 8, 2026
Anushka M SunderDirectorDec 17, 2025
Thomas W SweetDirectorJun 15, 2026
Stephen H. WiseDirectorJan 8, 2026

Executive officers

NameTitleLatest filing
William J AbramsSee RemarksJun 17, 2026
James M BoyleChief Executive OfficerAug 21, 2026
Jessi L CorcoranPrincipal Accounting OfficerJun 9, 2026
Michael B DrazinChief Financial OfficerJun 17, 2026
Douglas P GolwasChief Commercial OfficerJun 17, 2026
Amanda H. LaabsChief Product OfficerJun 17, 2026
Alexander M. LibermanChief Legal OfficerJun 17, 2026
Stephen L MillerChief Operating OfficerAug 21, 2026
James M PigottPresidentDec 17, 2025
Christopher P ShryockChief Human Resources OfficerJun 17, 2026

Recent insider buys & sales

DateInsiderTypeSharesPrice
Aug 14, 2026Investment Pte. Ltd. HuxSale100,000$35.80
Aug 14, 2026Private Ltd GicSale100,000$35.80
Aug 14, 2026Special Investments Pte Ltd GicSale100,000$35.80
Aug 13, 2026Investment Pte. Ltd. HuxSale1,500,000$35.80
Aug 13, 2026Private Ltd GicSale1,500,000$35.80
Aug 13, 2026Special Investments Pte Ltd GicSale1,500,000$35.80
Aug 7, 2026Private Ltd GicSale590,284$35.58
Aug 7, 2026Special Investments Pte Ltd GicSale590,284$35.58
Aug 7, 2026Investment Pte. Ltd. HuxSale590,284$35.58
Aug 6, 2026Investment Pte. Ltd. HuxSale271,994$35.33
Aug 6, 2026Private Ltd GicSale271,994$35.33
Aug 6, 2026Special Investments Pte Ltd GicSale271,994$35.33
Aug 5, 2026Investment Pte. Ltd. HuxSale265,711$36.48
Aug 5, 2026Investment Pte. Ltd. HuxSale1,710,907$35.46
Aug 5, 2026Private Ltd GicSale265,711$36.48

MDLN financials (annual, from XBRL filings)

Fiscal year endRevenueNet incomeDiluted EPSOperating cash flow
Dec 31, 2025$28.43B$1.16B-0.01$1.74B
Dec 31, 2024$25.51B——$1.77B
Dec 31, 2023$23.23B——$1.69B

Latest balance sheet: total assets $39.35B, total liabilities $20.27B, cash $2.33B (as of Jun 27, 2026).

MDLN earnings / results-day log

DateFilingClose that day
Aug 5, 20268-K Item 2.02 (results)$36.67
May 6, 20268-K Item 2.02 (results)$42.01
Feb 25, 20268-K Item 2.02 (results)$48.18

Related stocks · Surgical & Medical Instruments & Apparatus

Stryker (SYK)Boston Scientific (BSX)3M (MMM)MiniMed (MMED)Dexcom (DXCM)Becton Dickinson (BDX)Resmed (RMD)Insulet (PODD)West Pharmaceutical Services (WST)Globus Medical (GMED)

Popular today

Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)

More on MDLN

Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.